Literature DB >> 22087699

HRAS mutation mosaicism causing urothelial cancer and epidermal nevus.

Christian Hafner, Agusti Toll, Francisco X Real.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22087699     DOI： 10.1056/NEJMc1109381

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  22 in total

1.  Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.

Authors:  Leopold Groesser; Eva Herschberger; Arno Ruetten; Claudia Ruivenkamp; Enrico Lopriore; Markus Zutt; Thomas Langmann; Sebastian Singer; Laura Klingseisen; Wulf Schneider-Brachert; Agusti Toll; Francisco X Real; Michael Landthaler; Christian Hafner
Journal:  Nat Genet       Date:  2012-06-10       Impact factor: 38.330

Review 2.  Somatic mosaicism: on the road to cancer.

Authors:  Luis C Fernández; Miguel Torres; Francisco X Real
Journal:  Nat Rev Cancer       Date:  2015-12-18       Impact factor: 60.716

3.  Many mosaic mutations.

Authors:  W D Foulkes; F X Real
Journal:  Curr Oncol       Date:  2013-04       Impact factor: 3.677

4.  Epidermal, sebaceous, and melanocytic nevoid proliferations are spectrums of mosaic RASopathies.

Authors:  Su Luo; Hensin Tsao
Journal:  J Invest Dermatol       Date:  2014-10       Impact factor: 8.551

Review 5.  The duality of human oncoproteins: drivers of cancer and congenital disorders.

Authors:  Pau Castel; Katherine A Rauen; Frank McCormick
Journal:  Nat Rev Cancer       Date:  2020-04-27       Impact factor: 60.716

6.  Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.

Authors:  Young H Lim; Diana Ovejero; Jeffrey S Sugarman; Cynthia M C Deklotz; Ann Maruri; Lawrence F Eichenfield; Patrick K Kelley; Harald Jüppner; Michael Gottschalk; Cynthia J Tifft; Rachel I Gafni; Alison M Boyce; Edward W Cowen; Nisan Bhattacharyya; Lori C Guthrie; William A Gahl; Gretchen Golas; Erin C Loring; John D Overton; Shrikant M Mane; Richard P Lifton; Moise L Levy; Michael T Collins; Keith A Choate
Journal:  Hum Mol Genet       Date:  2013-09-04       Impact factor: 6.150

Review 7.  [Genetic basis of seborrheic keratosis and epidermal nevi].

Authors:  C Hafner; H Hafner; L Groesser
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

Review 8.  Mosaic RASopathies.

Authors:  Christian Hafner; Leopold Groesser
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

9.  HRAS mutations in bladder cancer at an early age and the possible association with the Costello Syndrome.

Authors:  Willemien Beukers; Aleksander Hercegovac; Ellen C Zwarthoff
Journal:  Eur J Hum Genet       Date:  2013-10-30       Impact factor: 4.246

10.  Activating FGFR3 mutations cause mild hyperplasia in human skin, but are insufficient to drive benign or malignant skin tumors.

Authors:  Elizabeth K Duperret; Seung Ja Oh; Andrew McNeal; Stephen M Prouty; Todd W Ridky
Journal:  Cell Cycle       Date:  2014-03-12       Impact factor: 4.534
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.